NEW YORK STATE COMMON RETIREMENT FUND - NGM BIOPHARMACEUTICALS INC ownership

NGM BIOPHARMACEUTICALS INC's ticker is NGM and the CUSIP is 62921N105. A total of 74 filers reported holding NGM BIOPHARMACEUTICALS INC in Q1 2020. The put-call ratio across all filers is - and the average weighting 1.2%.

Quarter-by-quarter ownership
NEW YORK STATE COMMON RETIREMENT FUND ownership history of NGM BIOPHARMACEUTICALS INC
ValueSharesWeighting
Q3 2023$11
-57.7%
10,272
+1.2%
0.00%
Q2 2023$26
-36.6%
10,1460.0%0.00%
Q1 2023$41
-69.2%
10,146
-61.6%
0.00%
Q4 2022$133
-100.0%
26,446
-0.1%
0.00%
-100.0%
Q3 2022$346,000
+18.9%
26,462
+16.5%
0.00%
Q2 2022$291,000
-16.1%
22,710
-0.3%
0.00%
Q1 2022$347,000
-13.9%
22,784
+0.1%
0.00%
Q4 2021$403,000
-16.2%
22,764
-0.5%
0.00%
-100.0%
Q3 2021$481,000
-10.4%
22,872
-15.9%
0.00%0.0%
Q2 2021$537,000
-16.1%
27,207
+23.7%
0.00%0.0%
Q1 2021$640,000
-3.9%
22,0000.0%0.00%0.0%
Q4 2020$666,000
+90.3%
22,0000.0%0.00%
Q3 2020$350,000
-19.4%
22,0000.0%0.00%
-100.0%
Q2 2020$434,000
+60.1%
22,0000.0%0.00%
Q1 2020$271,000
-33.4%
22,0000.0%0.00%
Q4 2019$407,000
+324.0%
22,000
+218.8%
0.00%
Q3 2019$96,000
-5.0%
6,9000.0%0.00%
Q2 2019$101,0006,9000.00%
Other shareholders
NGM BIOPHARMACEUTICALS INC shareholders Q1 2020
NameSharesValueWeighting ↓
Column Group LLC 18,136,735$19,406,30612.88%
StepStone Group LP 1,573,357$1,683,4920.38%
EcoR1 Capital, LLC 6,435,518$6,886,0040.23%
Euclidean Capital LLC 1,984,336$2,123,2400.23%
Boxer Capital, LLC 500,000$535,0000.03%
GSA CAPITAL PARTNERS LLP 213,676$2290.02%
Jasper Ridge Partners, L.P. 303,492$324,7360.02%
Carson Advisory Inc. 15,850$16,9600.02%
CORNERCAP INVESTMENT COUNSEL INC 51,176$54,7580.01%
Parkwood LLC 68,314$730.01%
View complete list of NGM BIOPHARMACEUTICALS INC shareholders